Skip to main content
logo
TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.7962
+0.0330 (4.32%)
At close: Aug 7, 2026, 4:00 PM EDT
0.8003
+0.0041 (0.51%)
After-hours: Aug 7, 2026, 7:34 PM EDT

TScan Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-124.31-129.77-127.5-89.22-66.22-48.63
Depreciation & Amortization
2.882.874.115.365.143.33
Stock-Based Compensation
10.7611.719.555.214.552.52
Other Adjustments
-0.78-1.95-2.03-0.320.26-
Changes in Accounts Payable
-2.52-3.011.99-0.050.530.01
Changes in Accrued Expenses
-0.91-7.234.533.850.733.23
Changes in Unearned Revenue
-9.14-10.33-2.8211.89-9.03-6.54
Changes in Other Operating Activities
1.882.381.341.92-2.46-2.6
Operating Cash Flow
-122.01-135.32-110.82-61.36-66.5-48.68
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.95-4.41-3.83-3.15-4.23-9.94
Purchases of Investments
-26.53-87.47-241.45-77.61--
Proceeds from Sale of Investments
125.25201.25192.6620--
Investing Cash Flow
95.77109.37-52.61-60.76-4.23-9.94

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--32.46-29.35-
Long-Term Debt Repaid
---17.14---
Net Long-Term Debt Issued (Repaid)
--15.31-29.35-
Issuance of Common Stock
-0.26193.45135.440.3389.94
Net Common Stock Issued (Repurchased)
-0.26193.45135.440.3389.94
Issuance of Preferred Stock
-----99.73
Net Preferred Stock Issued (Repurchased)
-----99.73
Other Financing Activities
-0.08-0.6---0.32-
Financing Cash Flow
0.19-0.34208.77135.4429.36189.67

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-26.05-26.2845.3313.33-41.37131.05

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-124.96-139.73-114.65-64.5-70.73-58.62
Free Cash Flow Growth
------
FCF Margin
-1367.74%-1353.28%-4071.27%-306.45%-522.56%-578.03%
Free Cash Flow Per Share
-0.96-1.08-1.02-0.98-2.94-5.03
Levered Free Cash Flow
-135.05-149.49-106.85-69.4-46.19-61.13
Unlevered Free Cash Flow
-139.45-155.53-129.48-73.64-75.95-61.15
SEC Filings: 10-K · 10-Q